Home > Share Market > Stocks > Glaxosmithkline Pharmaceuticals Ltd > Financial Statements > GLAXO Cash Flow

Glaxosmithkline Pharmaceuticals Ltd Financial Statements

Glaxosmithkline Pharmaceuticals Ltd Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2017 Mar-2016
Profit before tax 723 647 465 576
Depreciation (79) (83) (26) (25)
Tax paid (192) (213) (174) (202)
Working capital (818) (1,013) (771) 114
Other operating items -- -- -- --
Operating cashflow (367) (661) (506) 463
Capital expenditure 285 1,138 (38) (135)
Free cash flow (82) 478 (544) 328
Equity raised 2,907 3,565 3,744 3,996
Investments (112) (55) (10) 5.98
Debt financing/disposal 4.93 4.77 5.74 5.49
Dividends paid -- -- 254 529
Other items -- -- -- --
Net in cash 2,718 3,992 3,450 4,865

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000